Table 2 Comparison of clinical characteristics in HCC subtypes.
Characteristics | Cluster1(N = 267) | Cluster2(N = 96) | P value |
|---|---|---|---|
Gender (N = 363) | 0.05 | ||
Female | 79(29.6%) | 39(40.6%) | Â |
Male | 188(70.4%) | 57(59.4%) | Â |
Age (N = 363) | 0.42 | ||
<60 | 118(44.2%) | 47(49.0%) | Â |
≥ 60 | 149(55.8%) | 49(51.0%) |  |
Neoplasm-Histologic-Grade (N = 358) | <0.001 | ||
G1/G2 | 183(69.6%) | 47(49.5%) | Â |
G3/G4 | 80(30.4%) | 48(50.5%) | Â |
TNM Stage (N = 360) | <0.001 | ||
Stage I/II | 204(76.4%) | 32(33.3%) | Â |
Stage III/IV | 63(23.6%) | 64(66.7%) | Â |
Vascular infiltration (N = 309) | 0.07 | ||
Micro/Macro | 72(30.5%) | 32(43.8%) | Â |
None | 164(69.5%) | 41(71.2%) | Â |
Child-Pugh-Classification-Grade (N = 238) | 0.35 | ||
A | 168(89.8%) | 48(94.1%) | Â |
B/C | 19(10.2%) | 3(5.9%) | Â |
AFP (N = 363) | 0.01 | ||
≤ 400 | 169(80.9%) | 44(65.7%) |  |
>400 | 40(19.1%) | 23(34.3%) | Â |
Adjacent-Hepatic-Tissue-Inflammation-Extent-Type (N = 232) | 0.94 | ||
None | 91(50.6%) | 26(50.0%) | Â |
Mild/Severe | 89(49.4%) | 26(50.0%) | Â |
